AU2015335599B2 - Preparations of meta-iodobenzylguanidine and precursors thereof - Google Patents
Preparations of meta-iodobenzylguanidine and precursors thereof Download PDFInfo
- Publication number
- AU2015335599B2 AU2015335599B2 AU2015335599A AU2015335599A AU2015335599B2 AU 2015335599 B2 AU2015335599 B2 AU 2015335599B2 AU 2015335599 A AU2015335599 A AU 2015335599A AU 2015335599 A AU2015335599 A AU 2015335599A AU 2015335599 B2 AU2015335599 B2 AU 2015335599B2
- Authority
- AU
- Australia
- Prior art keywords
- preparation
- ppm
- polymer
- inert gas
- level
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 0 CCCC[Sn](CCCC)(CCCc1ccc(C(C*C)*C)cc1)c1cc(CNC(N)=N)ccc1 Chemical compound CCCC[Sn](CCCC)(CCCc1ccc(C(C*C)*C)cc1)c1cc(CNC(N)=N)ccc1 0.000 description 3
- PLOKKQPWVHLXKD-UHFFFAOYSA-N CCC(CC)C1[Si+](C)(C)N(Cc2cc(Br)ccc2)[Si+](C)(C)C1 Chemical compound CCC(CC)C1[Si+](C)(C)N(Cc2cc(Br)ccc2)[Si+](C)(C)C1 PLOKKQPWVHLXKD-UHFFFAOYSA-N 0.000 description 1
- AGIQGXPHGJAUDA-UHFFFAOYSA-N C[Sn]c1cc(CNC(N)=N)ccc1 Chemical compound C[Sn]c1cc(CNC(N)=N)ccc1 AGIQGXPHGJAUDA-UHFFFAOYSA-N 0.000 description 1
- KFUJWDJOCIAHRS-UHFFFAOYSA-N N=NNCC1=C[I]=CC=C1 Chemical compound N=NNCC1=C[I]=CC=C1 KFUJWDJOCIAHRS-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
- C08F230/00—Copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and containing phosphorus, selenium, tellurium or a metal
- C08F230/04—Copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and containing phosphorus, selenium, tellurium or a metal containing a metal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/0404—Lipids, e.g. triglycerides; Polycationic carriers
- A61K51/0406—Amines, polyamines, e.g. spermine, spermidine, amino acids, (bis)guanidines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C277/00—Preparation of guanidine or its derivatives, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
- C07C277/08—Preparation of guanidine or its derivatives, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups of substituted guanidines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C279/00—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
- C07C279/04—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to acyclic carbon atoms of a carbon skeleton
- C07C279/06—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to acyclic carbon atoms of a carbon skeleton being further substituted by halogen atoms, or by nitro or nitroso groups
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Physics & Mathematics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Optics & Photonics (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Polymers & Plastics (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Compositions Of Macromolecular Compounds (AREA)
- Medicinal Preparation (AREA)
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU2020204062A AU2020204062B9 (en) | 2014-10-24 | 2020-06-18 | Preparations of meta-iodobenzylguanidine and precursors thereof |
| AU2022204262A AU2022204262A1 (en) | 2014-10-24 | 2022-06-17 | Preparations of meta-iodobenzylguanidine and precursors thereof |
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201462068598P | 2014-10-24 | 2014-10-24 | |
| US62/068,598 | 2014-10-24 | ||
| US201462069029P | 2014-10-27 | 2014-10-27 | |
| US62/069,029 | 2014-10-27 | ||
| PCT/US2015/057222 WO2016065322A1 (en) | 2014-10-24 | 2015-10-23 | Preparations of meta-iodobenzylguanidine and precursors thereof |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2020204062A Division AU2020204062B9 (en) | 2014-10-24 | 2020-06-18 | Preparations of meta-iodobenzylguanidine and precursors thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| AU2015335599A1 AU2015335599A1 (en) | 2017-05-11 |
| AU2015335599B2 true AU2015335599B2 (en) | 2020-03-19 |
Family
ID=55174697
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2015335599A Active AU2015335599B2 (en) | 2014-10-24 | 2015-10-23 | Preparations of meta-iodobenzylguanidine and precursors thereof |
| AU2020204062A Active AU2020204062B9 (en) | 2014-10-24 | 2020-06-18 | Preparations of meta-iodobenzylguanidine and precursors thereof |
| AU2022204262A Abandoned AU2022204262A1 (en) | 2014-10-24 | 2022-06-17 | Preparations of meta-iodobenzylguanidine and precursors thereof |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2020204062A Active AU2020204062B9 (en) | 2014-10-24 | 2020-06-18 | Preparations of meta-iodobenzylguanidine and precursors thereof |
| AU2022204262A Abandoned AU2022204262A1 (en) | 2014-10-24 | 2022-06-17 | Preparations of meta-iodobenzylguanidine and precursors thereof |
Country Status (8)
| Country | Link |
|---|---|
| US (4) | US20160115267A1 (enExample) |
| EP (2) | EP3268052B1 (enExample) |
| JP (3) | JP7078396B2 (enExample) |
| CN (1) | CN107106710A (enExample) |
| AU (3) | AU2015335599B2 (enExample) |
| CA (1) | CA2965196C (enExample) |
| ES (1) | ES2916550T3 (enExample) |
| WO (1) | WO2016065322A1 (enExample) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2015335599B2 (en) | 2014-10-24 | 2020-03-19 | Molecular Insight Pharmaceuticals, Inc. | Preparations of meta-iodobenzylguanidine and precursors thereof |
| CN109666039B (zh) * | 2018-12-13 | 2020-12-25 | 山西大学 | 一种五核锡（ii）化合物及其制备方法和应用 |
| TWI898889B (zh) * | 2024-10-22 | 2025-09-21 | 國家原子能科技研究院 | 不含保護基之間三正丁基錫苯甲胍的製造方法 |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20030012730A1 (en) * | 2000-07-18 | 2003-01-16 | Hunter Duncan H. | Preparation of radiolabelled haloaromatics via polymer-bound intermediates |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4591630A (en) * | 1981-07-30 | 1986-05-27 | Ethicon, Inc. | Annealed polydioxanone surgical device and method for producing the same |
| US5565185A (en) | 1994-07-20 | 1996-10-15 | Merck Frosst Canada, Inc. | Process for the preparation of radiolabeled meta-halobenzylguanidine |
| US6461585B1 (en) * | 1998-10-02 | 2002-10-08 | The University Of Western Ontario | Preparation of radiolabelled haloaromatics via polymer-bound intermediates |
| US7335347B2 (en) * | 2002-10-18 | 2008-02-26 | Mcmaster University | Methods for purifying radiolabelled compounds |
| GB0514087D0 (en) | 2005-07-11 | 2005-08-17 | Ge Healthcare Ltd | Stabilised radiopharmaceutical compositions |
| TWI606842B (zh) | 2010-05-11 | 2017-12-01 | 藍瑟斯醫學影像公司 | 用於合成及使用造影劑之組合物、方法及系統 |
| AU2015335599B2 (en) | 2014-10-24 | 2020-03-19 | Molecular Insight Pharmaceuticals, Inc. | Preparations of meta-iodobenzylguanidine and precursors thereof |
-
2015
- 2015-10-23 AU AU2015335599A patent/AU2015335599B2/en active Active
- 2015-10-23 US US14/921,898 patent/US20160115267A1/en not_active Abandoned
- 2015-10-23 CN CN201580064695.2A patent/CN107106710A/zh active Pending
- 2015-10-23 ES ES15825978T patent/ES2916550T3/es active Active
- 2015-10-23 EP EP15825978.8A patent/EP3268052B1/en active Active
- 2015-10-23 WO PCT/US2015/057222 patent/WO2016065322A1/en not_active Ceased
- 2015-10-23 EP EP21173328.2A patent/EP3888694A1/en not_active Withdrawn
- 2015-10-23 JP JP2017540977A patent/JP7078396B2/ja active Active
- 2015-10-23 CA CA2965196A patent/CA2965196C/en active Active
-
2019
- 2019-06-11 US US16/437,061 patent/US11279784B2/en active Active
-
2020
- 2020-05-28 JP JP2020093440A patent/JP7186744B2/ja active Active
- 2020-06-18 AU AU2020204062A patent/AU2020204062B9/en active Active
-
2022
- 2022-02-14 US US17/671,128 patent/US11840592B2/en active Active
- 2022-03-22 JP JP2022045482A patent/JP7399996B2/ja active Active
- 2022-06-17 AU AU2022204262A patent/AU2022204262A1/en not_active Abandoned
-
2023
- 2023-11-07 US US18/503,465 patent/US20240174782A1/en not_active Abandoned
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20030012730A1 (en) * | 2000-07-18 | 2003-01-16 | Hunter Duncan H. | Preparation of radiolabelled haloaromatics via polymer-bound intermediates |
Non-Patent Citations (1)
| Title |
|---|
| Paulekuhn et al. "Trends in Active Pharmaceutical Ingredient Salt Selection based on Analysis of the Orange Book Database", J. Med. Chem. 2007, 50, 6665-6672. * |
Also Published As
| Publication number | Publication date |
|---|---|
| US20160115267A1 (en) | 2016-04-28 |
| US20190367653A1 (en) | 2019-12-05 |
| AU2020204062A1 (en) | 2020-07-09 |
| JP2020143300A (ja) | 2020-09-10 |
| JP7078396B2 (ja) | 2022-05-31 |
| US11279784B2 (en) | 2022-03-22 |
| JP2022084797A (ja) | 2022-06-07 |
| JP2017534742A (ja) | 2017-11-24 |
| US20240174782A1 (en) | 2024-05-30 |
| AU2020204062B9 (en) | 2022-07-21 |
| HK1249425A1 (zh) | 2018-11-02 |
| WO2016065322A1 (en) | 2016-04-28 |
| EP3268052B1 (en) | 2021-06-23 |
| ES2916550T3 (es) | 2022-07-01 |
| AU2022204262A1 (en) | 2022-07-21 |
| CA2965196A1 (en) | 2016-04-28 |
| CN107106710A (zh) | 2017-08-29 |
| EP3268052A1 (en) | 2018-01-17 |
| US20230008878A1 (en) | 2023-01-12 |
| JP7399996B2 (ja) | 2023-12-18 |
| US11840592B2 (en) | 2023-12-12 |
| AU2020204062B2 (en) | 2022-07-07 |
| EP3888694A1 (en) | 2021-10-06 |
| AU2015335599A1 (en) | 2017-05-11 |
| CA2965196C (en) | 2024-01-23 |
| JP7186744B2 (ja) | 2022-12-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20240174782A1 (en) | Preparations of meta-iodobenzylguanidine and precursors thereof | |
| Huclier-Markai et al. | Optimization of reaction conditions for the radiolabeling of DOTA and DOTA-peptide with 44m/44Sc and experimental evidence of the feasibility of an in vivo PET generator | |
| CN102271716B (zh) | 由甲苯磺酸酯前体合成18f-放射性标记的苯乙烯基吡啶及其稳定的药物组合物 | |
| AU2014308140B2 (en) | Method for the quantification of 227Ac in 223Ra compositions | |
| TWI486617B (zh) | 一種測定對鎝（Ｔｃ－９９ｍ）與錸（Ｒｅ－１８６、Ｒｅ－１８８）具有穩定錯合力之含硫螯合劑在凍晶劑中之含量與均一性的固態樣品分析技術 | |
| WO2023246830A1 (zh) | 一种化合物ⅰ液体组合物的制备方法、及其在心肌代谢pet显像上的用途 | |
| CN116251199A (zh) | 结合α-突触核蛋白聚集体的小分子探针及其用途 | |
| CN115702009A (zh) | 用于放射性标记psma结合配体的方法及其试剂盒 | |
| HK40061461A (en) | Preparations of meta-iodobenzylguanidine and precursors thereof | |
| HK1249425B (en) | Preparations of meta-iodobenzylguanidine and precursors thereof | |
| Chen et al. | GMP-compliant automated radiosynthesis of [18F] SynVesT-1 for PET imaging of synaptic vesicle glycoprotein 2 A (SV2A) | |
| Brinkevich et al. | Autoradiolytic Decomposition of Radiopharmaceutical 2-[18F] Fluorodeoxyglucose | |
| CN211999536U (zh) | 一种[18f]d3fsp的自动化制备装置 | |
| Venkatachalam et al. | Synthesis of 18F‐radiolabeled diphenyl gallium dithiosemicarbazone using a novel halogen exchange method and in vivo biodistribution | |
| Dougan et al. | Kit type labelling of [123I] metaiodobenzylguanidine | |
| CN113372348A (zh) | 一种氘代FP-β-CIT及其制备方法与应用 | |
| CN213202877U (zh) | 一种d6-[18f]fp-(+)-dtbz的自动化制备装置 | |
| WO2001070699A1 (en) | Azure a analogues useful as probes in the diagnostic imaging for diseases due to accumulation of amyloid and compositions for diagnostic imaging containing the analogues | |
| Varlamova et al. | Synthesis and Study of Norfloxacin Labeled with Technecium-99m as a Potential Imaging Agent of Bacterial Inflammations | |
| Greiser et al. | Investigations on the Ga (III) complex of EOB-DTPA and its 68Ga radiolabeled analogue | |
| CN119874752A (zh) | 一种Al18F标记的PSMA放射性药物、制备方法及其应用 | |
| Ferris | Zirconium-89 Complexes for Cell Tracking with Positron Emission Tomography |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FGA | Letters patent sealed or granted (standard patent) |